Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $27.7200 (-4.61%) ($27.6800 - $29.3080) on Thu. Nov. 12, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.07% (three month average) | RSI | 36 | Latest Price | $27.7200(-4.61%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.6% a day on average for past five trading days. | Weekly Trend | EDIT declines -4.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(61%) IWO(57%) ARKG(54%) IWC(54%) IBUY(53%) | Factors Impacting EDIT price | EDIT will decline at least -2.035% in a week (0% probabilities). VIXM(-28%) UUP(-15%) VXX(-12%) EDOC(-9%) TBT(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.035% (StdDev 4.07%) | Hourly BBV | -2.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $19.98(-27.92%) | Resistance Level | $31.15 | 5 Day Moving Average | $29.52(-6.1%) | 10 Day Moving Average | $29.98(-7.54%) | 20 Day Moving Average | $31.15(-11.01%) | To recent high | -25.3% | To recent low | 2.3% | Market Cap | $1.722b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |